Uncategorized Archives - dabl Clinical Trials

22 Sep 2021

Athens, Greece, Sept. 14, 2021 – European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented an updated position paper on renal denervation (RDN) during the 8th pre-ESH congress satellite symposium in Athens, Greece from September 10-11, 2021 . The paper was recently published in the September issue of the Journal of Hypertension.

{...} click to continue

New Hypertension Core Lab partnership
15 Jul 2021

Hypertension affects a substantial part of the world’s population. Treatment options include lifestyle changes and drug-based therapies. Device-based therapies for hypertension are under development and used within the context of clinical studies and randomized controlled and sham-controlled trials. Research on device-based therapies for hypertension typically use ambulatory blood pressure monitoring (ABPM) as primary endpoint. Key […]

{...} click to continue

dabl’s quality meeting the highest standards
21 Oct 2020

Certification Europe issues ISO 9001:2015 Surveillance Assessment report and certificate to dabl Limited stating no issues of nonconformity were detected during the assessment and that dabl’s Quality Management System continues to satisfy the requirements of the company.

{...} click to continue

dabl ensures uninterrupted clinical trial workflow in COVID-19 pandemic
14 Apr 2020

The dabl ABPM system and ABPM device logistics service obviates hospital trial site visits during this COVID-19 pandemic resulting in uninterrupted workflow. The FDA Guidance on Conduct of Clinical Trials of Medical Products during the COVID-19 Pandemic – updated April 2, 2020 – allows for changes to be made to the investigational plan or protocol […]

{...} click to continue

OCT West Coast 2020 March 3-4 San Francisco
25 Feb 2020

Meet the dabl team at: Outsourcing in Clinical Trials (OCT) West Coast 2020, Hyatt Regency San Francisco Airport, 3rd-4th March, 2020. We would love to meet you there!

{...} click to continue

#Wear Red Day – February 1st 2019
01 Feb 2019

Why is dabl® Going RED? Cardiovascular diseases kill 1 woman every 80 seconds yet 80% of these cases may be prevented with education and action. According to the American Heart Association increasing physical activity, healthy eating and regularly monitoring your Blood Pressure will help enormously in preventing cardiovascular disease.      

{...} click to continue

Hypertension and Chronic Obstructive Pulmonary Disease (COPD)
21 Nov 2018

Hypertension is a condition that prevails globally and is estimated to affect over one billion people. It occurs irrespective of income status but is more common with advancing age. Physical inactivity and increasing body weight are significant contributory factors to developing hypertension. On this, #WorldCOPDDay it is worth noting the correlation between COPD, hypertension and […]

{...} click to continue

How are diabetes and hypertension linked?
14 Nov 2018

Hypertension, otherwise known as Blood Pressure can affect people with Type 1 or Type 2 Diabetes. In most cases Hypertension has no signs or symptoms and this is why it is often referred to as the silent killer. According to the American Diabetes Association 71% of adults with diabetes had a blood pressure of greater than […]

{...} click to continue